Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.94K Sell
500
-89
-15% -$1.38K ﹤0.01% 588
2026
Q1
$7.96K Hold
589
﹤0.01% 578
2025
Q4
$7.33K Buy
589
+50
+9% +$539 ﹤0.01% 567
2025
Q3
$5.34K Buy
539
+39
+8% +$380 ﹤0.01% 590
2025
Q2
$4.46K Hold
500
﹤0.01% 567
2025
Q1
$4.36K Hold
500
﹤0.01% 559
2024
Q4
$6.22K Sell
500
-12
-2% -$147 ﹤0.01% 544
2024
Q3
$5.95K Buy
512
+12
+2% +$138 ﹤0.01% 532
2024
Q2
$5.32K Hold
500
﹤0.01% 521
2024
Q1
$5.97K Hold
500
﹤0.01% 538
2023
Q4
$5.42K Buy
+500
New +$4.79K ﹤0.01% 499

Other funds holding VTRS

BFSG LLC's VTRS Position: Q2 2026 in Review

BFSG LLC reduced its Viatris (VTRS) stake by 15% in Q2 2026, selling an estimated $1.38K and leaving 500 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

BFSG LLC first reported a position in VTRS in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.96K in Q1 2026. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • BFSG LLC held 500 shares of Viatris worth $7.94K as of Q2 2026.
  • BFSG LLC sold 89 Viatris shares in Q2 2026, an estimated $1.38K.
  • Viatris made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #588 holding.
  • BFSG LLC first reported a position in Viatris in Q4 2023 and has held it in 11 quarters since.
  • BFSG LLC's Viatris position peaked at $7.96K in Q1 2026.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.